KTTA - Pasithea Therapeutics Corp. Operating income before deduction of amortization
Pasithea Therapeutics (KTTA) generates revenue through the operations of specialized ketamine infusion therapy centers. The EBITDA distribution across periods confirms the current financial momentum, where the value of 0.00 reflects this status. The company's prospects rely on the launch of small molecule trials in neurobiology and oncology. High human capital potential is secured by attracting schizophrenia experts through an RSU and options system.
Pasithea Therapeutics Corp. (KTTA) - metric breakdowns and financial figures
- stock value and consensus price forecast:
- market capitalization statistics:
- balance sheet equity data:
- company total debt and liquidity indicators:
Debt to Capital Pasithea Therapeutics|KTTA - Long-Term Debt to Capital|Short-Term Debt to Capital Pasithea Therapeutics Corp|KTTA - Company Total Debt|Debt to Net Assets Ratio Pasithea Therapeutics|KTTA - Company Long-Term Liabilities|Amount of Current Liabilities Pasithea Therapeutics|Intermediate Coverage Ratio pasitheaclinics.com
- financial results and valuation multiples details:
KTTA - Net Profit|Expected Net Profit Pasithea Therapeutics|KTTA - Price to Earnings Ratio|Future Price to Earnings Multiple Pasithea Therapeutics Corp|KTTA - PEG Multiple|EV/EBITDA Multiple Pasithea Therapeutics|KTTA - Profit before payment of interest, taxes and amortization|Earnings per one share for the last 12 months Pasithea Therapeutics|KTTA - Net earnings per share (EPS TTM)|Earnings per share growth in annualized terms for the last twelve months pasitheaclinics.com|KTTA - Net earnings per share growth this year|Earnings growth forecast for next year Pasithea Therapeutics
Fundamental company valuation:Pasithea Therapeutics
This metric measures net cash flow from operating activities before taxes and depreciation, allowing for an assessment of the real efficiency of operational processes excluding accounting write-offs. Given the conservative management of clinical programs at Pasithea Therapeutics (KTTA), the EBITDA trend serves as the primary tool for monitoring spending discipline, identifying accidental cash spikes unrelated to fundamental business growth.
Competitor analysis for Pasithea Therapeutics
Operating income before deduction of amortization Biogen Idec (BIIB)|Neurocrine Biosciences - Operating profit EBITDA|Operating income before deduction of amortization regencellbioscience.com RGC|AXSM (Axsome Therapeutics, Inc.) - Operating profit before deduction of amortization|ACAD: Company profit before taxes, interest and amortization|XENE (Xenon Pharmaceuticals Inc) - Operating profit EBITDA|VKTX: Income before deduction of interest, taxes and amortization|Operating profit EBITDA SUPN|CPRX - Profit before interest, taxes and amortization|Operating profit EBITDA DNLI (Denali Therapeutics Inc.)|Operating profit EBITDA Harmony Biosciences Inc HRMY|BHVN: Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization AMLX (Amylyx Corp)|TRVI (Trevi Therapeutics) - Operating profit before deduction of amortization|PRAX: Company profit before taxes, interest and amortization|AVXL (Anavex Life Sciences Corp.) - Operating profit EBITDA|CBLL: Income before deduction of interest, taxes and amortization|Operating profit EBITDA PRTA|ALEC - Profit before interest, taxes and amortization|Profit before payment of interest, taxes and amortization Annexon, Inc. ANNX|Income before deduction of interest, taxes and amortization OMER|Neurogene - Operating profit EBITDA|ACIU - Operating profit EBITDA|Voyager Pharma (VYGR) - Profit before payment of interest, taxes and amortization|Profit before deduction of interest, taxes, depreciation and amortization NMRA (Neumora Corp)|SCLX (Scilex Holding Company) - Operating profit EBITDA|Profit before interest, taxes and amortization tevogen.com TVGN|Operating profit before deduction of amortization ACOG (Alpha Cognition)|Operating profit EBITDA Cognition Therapeutics Inc. (CGTX)|Inhibikase - Operating profit before deduction of amortization|Company profit before taxes, interest and amortization SAVA (Cassava Pharma)|Assertio Therapeutics - Operating profit EBITDA|Operating income before deduction of amortization Coya Therapeutics, Inc. COYA|VTGN: Operating profit EBITDA|Operating profit before deduction of amortization Ovid Therapeutics|Profit before payment of interest, taxes and amortization Acumen Pharma|CervoMed Corporation (CRVO) - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Alterity Therapeutics (ATHE)|Operating profit EBITDA clene.com (CLNN)|PepGen - Operating profit before deduction of amortization|Company profit before taxes, interest and amortization JUNS (Jupiter Neurosciences, Inc.)|RLMD: Operating profit before deduction of amortization|Annovis Bio Corporation - Company profit before taxes, interest and amortization|GRCE: Operating profit EBITDA|fireflyneuro.com (AIFF) - Operating profit EBITDA|Profit before payment of interest, taxes and amortization ANEW Medical|Operating profit before amortization NRSN (NeuroSense Therapeutics, Ltd.)|Operating profit EBITDA RVPH|MTVA - Profit before interest, taxes and amortization|NeurAxis, Inc. - Operating profit before deduction of amortization|Operating profit EBITDA Helius Medical Technologies, Inc. HSDT|PASG - Profit before payment of interest, taxes and amortization|Income before deduction of interest, taxes and amortization NEUP (Neuphoria Therapeutics Inc.)|Minerva Neurosciences Corp (NERV) - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization Athira Pharma Corp (ATHA)|Profit before payment of interest, taxes and amortization Addex Therapeutics|Alzamend - Profit before deduction of interest, taxes, depreciation and amortization|Operating profit EBITDA CYCN|Operating profit EBITDA protagenic.com (PTIX)|Profit before payment of interest, taxes and amortization Cortigent CRGT|Operating income before deduction of amortization Avenue Therapeutics Inc (ATXI)|Brainstorm Cell - Operating profit EBITDA|Operating income before deduction of amortization caratherapeutics.com CARA|CHRO (Chromocell Therapeutics Corp.) - Operating profit before deduction of amortization|ELYM: Company profit before taxes, interest and amortization|ITCI (Intra-Cellular Therapies Inc.) - Operating profit EBITDA|LBPH: Income before deduction of interest, taxes and amortization|Operating profit EBITDA MRNS|NKGN - Profit before interest, taxes and amortization|Operating profit EBITDA NRBO (NeuroBo Pharmaceuticals, Inc.)|Operating profit EBITDA Sage Therapeutics Inc. SAGE|SNPX: Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization TRVN (Trevena Inc)|VIGL (vigilneuro.com) - Operating profit before deduction of amortization|WENA: Company profit before taxes, interest and amortization|CERE (Cerevel Therapeutics, Inc.) - Operating profit EBITDA
